Corona Remedies made a robust debut on Dalal Street on Monday, December 15, with its shares listing at a hefty premium over the issue price. On the NSE, the stock opened at ₹1,470, marking a gain of 38.42% over the IPO price of ₹1,062, while on the BSE it listed at ₹1,452, up 36.72%. The […]Continue Reading
